First Advantage Corporation has acquired Data Diver Technologies for approximately $125 million to enhance its proprietary data and technology capabilities. Data Diver's AI-powered platform improves automated collection and coverage of criminal and court records, supporting faster and more accurate background screening. The acquisition expands First Advantage's automated fulfillment across U.S. jurisdictions and strengthens its product innovation, aiming to deliver quicker, high-quality screening results. The Data Diver management team will stay on to ensure smooth integration and continued growth.
First Advantage's acquisition of Data Diver Technologies offers context for readers interested in technology stocks. For readers following technology-sector stocks on Pluang, here is the market snapshot as of Nov 05, 2026 16:51 WIB: out of 150 priced US technology stocks, 37 rose and 108 fell. Taskus Inc (TASK) rose 10.08% to USD 9.50 with a typical hold time of 36 days. United Microelectronics Corp (UMC) fell 6.60% to USD 15.00 with 72% sell order activity and a 44-day hold time. ASE Technology Holding Co Ltd (ASX) dropped 5.57% to USD 35.42 with balanced order activity and a 50-day hold time.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
